• TaqI Restriction Endonuclease Protocol Guide

  2026-08-12

  TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the 5′-TCGA-3′ site, producing sticky ends for cloning and DNA analysis. It is intended for research workflows requiring fast digestion and should not be used for diagnostic, clinical, or medical applications.

• ApexPrep DNA Plasmid Miniprep Kit for AML

  2026-08-12

  The ApexPrep DNA Plasmid Miniprep Kit supports reproducible plasmid DNA extraction for cloning, sequencing, and AML perturbation studies. This article connects alkaline lysis chemistry with the LMO2–LDB1 evidence framework and explains how plasmid quality influences assay interpretation.

• EZ Cap™ Cy5 EGFP mRNA: Assay Design

  2026-08-11

  Discover how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates mRNA uptake from translation in advanced delivery studies. This guide connects dual-fluorescence reporter design with electroporation research in heterogeneous blood-cell systems, offering practical strategies for stronger assay interpretation.

• BCL-XL inhibitor A-1155463 Workflow

  2026-08-11

  Build a mechanism-first apoptosis workflow around the selective BCL-XL inhibitor A-1155463, from DMSO handling and dependency mapping to orthogonal cell-death validation. The guide also shows how to interpret BCL-XL/MCL-1 cooperation, platelet findings, and resistance biology without overstating preclinical evidence.

• TCAIM, OGDH, and Mitochondrial Proteostasis

  2026-08-10

  The 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. This finding expands the role of mitochondrial proteostasis from protein folding to post-translational control of a rate-limiting metabolic enzyme, with consequences for OGDH complex activity and carbohydrate catabolism.

• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-08-09

  E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA and can support PCR product contamination elimination when uracil-containing DNA is the contamination target. It is intended for research use with DNA substrates, not RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.

• Intravesical p21 mRNA–LNPs in Bladder Cancer

  2026-08-08

  The reference study develops a nonviral lipid nanoparticle platform for local delivery of chemically modified p21 mRNA to bladder tumors. Its data show that intravesical p21 restoration suppresses tumor growth through cell-cycle inhibition, DNA-damage accumulation, and apoptosis while limiting systemic exposure.

• Fluorinated-Sorbitol Polyplexes for mRNA Vaccines

  2026-08-07

  This study develops fluorinated polyethyleneimine functionalized with sorbitol as a dual-mechanism polyplex for mRNA delivery. The formulation improved cellular entry and endosomal escape, enabled luciferase expression in cells and mice, and generated SARS-CoV-2 neutralizing responses comparable to a Moderna lipid nanoparticle formulation.

• Prevotella copri, IPyA Depletion, and Breast Cancer Progress

  2026-08-07

  This article examines how Prevotella copri, an enriched gut bacterium in breast cancer patients, accelerates tumor progression by depleting host indole-3-pyruvic acid (IPyA). The study reveals a novel mechanistic axis where IPyA exhaustion leads to UHRF1-mediated AMPK inactivation, highlighting new targets for microbiome-related cancer research.

• Copper Single-Atom MOFs Enable Ultrasound-Enhanced Cancer Th

  2026-08-06

  This study introduces a copper single-atom-based metal–organic framework (MOF) engineered for ultrasound (US)-activated chemodynamic therapy (CDT) in cancer. The research demonstrates that single-atom Cu sites maximize catalytic efficiency and tumor targeting, with in vivo imaging and therapy validated using a NIR-II fluorescent dye.

• Mitomycin C in Cancer Research: Mechanistic Insights and Evo

  2026-08-06

  Explore the multifaceted role of Mitomycin C as an antitumor antibiotic, with a focus on its advanced applications in apoptosis signaling and cancer research. This article offers a unique, mechanism-centered perspective—distinct from standard protocols—grounding assay choices in the latest molecular insights.

• Ruxolitinib (INCB018424): Reliable Solutions for JAK-STAT As

  2026-08-05

  This scenario-driven guide addresses common laboratory challenges in JAK-STAT pathway and myeloproliferative disorder research, demonstrating how Ruxolitinib (INCB018424) (SKU A3012) from APExBIO delivers reproducible, quantitative results. Evidence-backed Q&A blocks clarify protocol design, data interpretation, and product selection for rigorous cell-based assays.

• Parathyroid hormone (1-34) (human): New Insights into Valvul

  2026-08-05

  Uncover the multifaceted role of Parathyroid hormone (1-34) (human) in valvular calcification and bone metabolism research. This in-depth analysis integrates molecular mechanisms, recent breakthroughs, and practical assay guidance for advanced experimental models.

• Maximizing NIR-II Fluorescence: Rational Liposome Design wit

  2026-08-04

  The referenced study presents a systematic approach to optimizing near-infrared II (NIR-II) fluorescent nanosystems by tailoring the encapsulation of IR-1061 in liposomes of varying charge. Key findings clarify how liposome surface charge and dye aggregation state dictate fluorescence intensity and in vivo imaging performance, providing actionable insights for designing high-performance optical probes in biomedical research.

• Pentoxifylline as an ICAM-1 Modulator: A Paradigm in Inflamm

  2026-08-04

  Explore how Pentoxifylline, a leading phosphodiesterase inhibitor, uniquely downregulates ICAM-1 in monocytes and advances anti-inflammatory research. This article reveals novel mechanistic insights and practical guidance for immunology workflows.

16395 records 1/1093 page Next 12345 下5页 Last page